Proteomic identification of C/EBPa multiprotein complex reveals that JNK1, an activator of C/EBPa is downregulated in patients with acute myeloid leukemia (AML)

Arun Kumar Trivedi(Central Drug Research Institute)

Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)

January 1, 2006

10.5282/edoc.5021

Cited by 0

Related Papers

Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation

|Oncotarget|2015|19

Nano‐LC based proteomic approach identifies that E6AP interacts with ENO1 and targets it for degradation in breast cancer cells

|IUBMB Life|2019|8

Ring finger protein 138 inhibits transcription factor C/EBPα protein turnover leading to differentiation arrest in acute myeloid leukemia

|Biochemical Journal|2024|3